Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the highest quintile among peers.
MainStay Balanced C MBACX
- NAV / 1-Day Return 29.48 / +0.34 %
- Total Assets 448.5 Mil
-
Adj. Expense Ratio
- Expense Ratio 2.080%
- Distribution Fee Level High
- Share Class Type Level Load
- Category Moderate Allocation
- Investment Style Large Value
- Credit Quality / Interest Rate Sensitivity —
- Status Open
- TTM Yield 1.11%
- Turnover 313%
USD | NAV as of May 03, 2024 | 1-Day Return as of May 03, 2024, 10:14 PM GMT+0
Morningstar’s Analysis MBACX
Will MBACX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 29.1
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
United States Treasury Notes 4.625% | 6.24 | 28.8 Mil | Government |
United States Treasury Notes 4.25% | 4.45 | 20.6 Mil | Government |
iShares Intermediate Govt/Crdt Bd ETF | 3.70 | 17.1 Mil | — |
United States Treasury Notes 4.25% | 3.08 | 14.2 Mil | Government |
JPMorgan Chase & Co | 2.36 | 10.9 Mil | Financial Services |
United States Treasury Notes 4.25% | 2.18 | 10.1 Mil | Government |
Vanguard Russell 1000 Value ETF | 2.10 | 9.7 Mil | — |
Merck & Co Inc | 1.69 | 7.8 Mil | Healthcare |
Johnson & Johnson | 1.68 | 7.7 Mil | Healthcare |
iShares Russell 1000 Value ETF | 1.65 | 7.6 Mil | — |